Charles A. Rowland Jr. - 01 Aug 2020 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
01 Aug 2020
Net transactions value
-$1,487
Form type
4
Filing time
03 Aug 2022, 21:48:50 UTC
Next filing
04 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Sale $1,487 -8,496 -36% $0.1750* 15,277 01 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.